APA (7th ed.) Citation

Glutsch, V., Grän, F., Weber, J., Gesierich, A., Goebeler, M., & Schilling, B. (2019). Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy. Journal for immunotherapy of cancer, 7(1), 181-5. https://doi.org/10.1186/s40425-019-0655-4

Chicago Style (17th ed.) Citation

Glutsch, Valerie, Franziska Grän, Judith Weber, Anja Gesierich, Matthias Goebeler, and Bastian Schilling. "Response to Combined Ipilimumab and Nivolumab After Development of a Nephrotic Syndrome Related to PD-1 Monotherapy." Journal for Immunotherapy of Cancer 7, no. 1 (2019): 181-5. https://doi.org/10.1186/s40425-019-0655-4.

MLA (9th ed.) Citation

Glutsch, Valerie, et al. "Response to Combined Ipilimumab and Nivolumab After Development of a Nephrotic Syndrome Related to PD-1 Monotherapy." Journal for Immunotherapy of Cancer, vol. 7, no. 1, 2019, pp. 181-5, https://doi.org/10.1186/s40425-019-0655-4.